Vaxxinity(VAXX) - 2023 Q2 - Quarterly Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 | FORM 10-Q | | | | --- | --- | --- | | (Mark One) | | | | ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | | | | For the quarterly period ended June 30, 2023 | | | | -OR- | | | | ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIESEXCHANGE ACT OF 1934 | | | | For the transition period from _________ to _________ | | | | Commission file number 001-41058 | | | | Vaxxinity, Inc. ...